Alterations in inflammatory and coagulation variables in COVID-19 patients

• Conditions: U07.1; J18.9; COVID-19, virus identified; Pneumonia, unspecified

• Registration Number: DRKS00021581
• Lead Sponsor: Klinikum der Universität München, Klinik für Anaesthesiologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-27
• Study Completion: 2021-02-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

1. Written informed consent to study participation
2. Age > 18 years.
3. Confirmed or suspected COVID-19 infection with the need of in hospital care.

Exclusion Criteria

1. Denial of the patient
2. Patients transferred from other hospitals.
3. Missing COVID-19 testing
4. prehospital intubation

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Association between coagulation alterations and course of COVID-19-disease

Secondary Outcome Measures

Name	Time	Method
length of hospital stay, infectious variables, death